<DOC>
	<DOCNO>NCT00190255</DOCNO>
	<brief_summary>Gastrointestinal bleeding severe adverse effect occur subject secondary use nonsteroidal anti-inflammatory drug ( NSAIDs ) . The enzyme CYP2C9 responsible elimination several NSAIDs . This protein inactive 12 % subject genetic mutation . We hypothesize individual carry mutation high risk gastrointestinal bleeding since display decrease NSAIDs elimination .</brief_summary>
	<brief_title>Pharmacogenetics Gastrointestinal Bleeding</brief_title>
	<detailed_description>Gastrointestinal bleeding severe adverse effect occur subject secondary use nonsteroidal anti-inflammatory drug ( NSAIDs ) . The enzyme CYP2C9 responsible elimination NSAIDs . Several polymorphism observe CYP2C9 . Of , CYP2C9*3 allele , find 12 % caucasian subject , lead reduced function enzyme . We hypothesize individual carry mutation high risk gastrointestinal bleeding since display decrease elimination NSAIDs . The purpose study determine whether frequency CYP2C9*3 variant allele increase subject use NSAIDs metabolize CYP2C9 comparison subject NSAIDs metabolize enzyme . The study group consist 200 patient suffer gastrointestinal bleeding NSAIDs use , divide 100 patient use NSAIDs metabolize CYP2C9 100 patient use NSAIDs .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Upper gastrointestinal bleeding reveal hematemesis , melena lower least 2g/dl haemoglobin Endoscopic report gastrointestinal ulcer haemorrhagic lesion Immediate antecedent NSAID therapy Cirrhosis ( Child B C ) Coma Concomitant therapy substrates inhibitor CYP2C9 : ketoconazole , itraconazole , ritonavir , phenobarbital , rifampicin , depakine , phenytoin , St John 's wort Patients treat NSAID metabolize CYP2C9 NSAID metabolize CYP2C9</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>gastrointestinal haemorrhage</keyword>
	<keyword>stomach ulcer</keyword>
	<keyword>anti-inflammatory agent , non-steroidal</keyword>
	<keyword>CYP2C9 protein , human</keyword>
	<keyword>genotype</keyword>
	<keyword>pharmacogenetics</keyword>
</DOC>